3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
6
Prostatic Neoplasms
4
Nasopharyngeal Carcinoma
4
Carcinoma, Hepatocellular
4
Sarcoma
2
Radiation Injuries
2
Melanoma
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Vulvar Neoplasms
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thymoma
1
Thymic epithelial tumor
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Rectal Neoplasms
1
Pancreatic Cancer Non-resectable
1
Ovarian Neoplasms
1
Osteosarcoma
1
Meningioma
1
Locally Advanced Pancreatic Cancer
1
Glioma
1
Chondrosarcoma
1
Carcinoma, Transitional Cell
1
Breast Neoplasms
1
Adenocarcinoma
1
Interventions
Gemcitabine
6
130-nm albumin-bound paclitaxel
4
S 1 (combination)
2
Radiosurgery
2
Oxaliplatin
2
Leucovorin
2
Fluorouracil
2
Electroporation
2
zimberelimab
1
surufatinib
1
Irinotecan
1
Immunotherapy
1
Heavy Ion Radiotherapy
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Locally Advanced Pancreatic Cancer
×
Heavy Ion Radiotherapy
×
Clear all
NCT01795274
2018-05-17
PHOENIX-01
University Hospital Heidelberg
Phase NA
Withdrawn